AzTrials
AzTrials

Hysterectomy, Benign Uterine DiseasesNCT07626684

Effect of Abdominal Ice Pack After vNOTES Hysterectomy

A study testing Abdominal Ice Pack + ERAS in people with Hysterectomy, Benign Uterine Diseases and Hysterectomy, Vaginal, run by Erzincan Military Hospital at 1 site in Turkey (Türkiye).

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized, controlled, open-label, parallel-group clinical trial is designed to investigate the efficacy of abdominal ice pack application as an adjunct to standard pain management following vNOTES (Vaginal Natural Orifice Transluminal Endoscopic Surgery) hysterectomy. Read more about this study

Who is it for?
Ages 48 to 70 years, women only
What is being tested?
Abdominal Ice Pack + ERAS
Could I receive a placebo?
No, everyone receives an active treatment
How many people
122 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Oct 2026to 15 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 48 to 70 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Scheduled to undergo elective vaginal natural orifice transluminal endoscopic surgery hysterectomy.
  • Patients with benign gynecological indications including uterine leiomyoma, adenomyosis, or abnormal uterine bleeding.
  • Patients with premalignant gynecological indications including atypical endometrial hyperplasia or cervical intraepithelial neoplasia.
  • Patients managed strictly under the standardized institutional Enhanced Recovery After Surgery protocol.
  • Patients with an American Society of Anesthesiologists physical status classification of I or II.
  • Patients who demonstrate adequate cognitive capacity to understand and utilize the Visual Analog Scale and Face Pain Index.
  • Patients who voluntarily provide signed written informed consent prior to participating in the clinical study.

Who cannot join

  • Patients with a documented history of chronic pelvic pain or systemic chronic pain syndromes.
  • Patients with known hypersensitivity, allergy, cold urticaria, or intolerance to local cryotherapy or cold applications.
  • Patients with a history of prior major open abdominal surgery
  • Active pregnancy, suspected pregnancy, or current lactation status at the time of enrollment.
  • Patients with severe systemic diseases including uncontrolled diabetes mellitus, severe hepatic impairment, or end-stage renal disease.
  • Coagulation disorders, active bleeding diathesis, or patients on mandatory continuous anticoagulant therapy.
Show all 10Show fewer
  • Diagnosed psychiatric disorders, severe depression, anxiety, or cognitive impairment preventing valid clinical outcome scoring.
  • Intraoperative conversion from vaginal natural orifice transluminal endoscopic surgery to conventional laparoscopy or open laparotomy.
  • Patients experiencing major intraoperative complications including severe vascular, bladder, bowel, or ureteral injury.
  • Patients requiring perioperative blood product transfusion due to significant estimated blood loss during surgery.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Mugla Sitki Kocman University

    Muğla, 48000

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Abdominal Ice Pack on Postoperative Pain, Bowel Motility, and Patient Comfort Following vNOTES Hysterectomy

This randomized, controlled, open-label, parallel-group clinical trial is designed to investigate the efficacy of abdominal ice pack application as an adjunct to standard pain management following vNOTES (Vaginal Natural Orifice Transluminal Endoscopic Surgery) hysterectomy. Participants will be randomized in a 1:1 ratio into either the intervention group (ice pack application) or the control group (standard care). Patients in the control group will receive postoperative care adhering strictly to the standard ERAS (Enhanced Recovery After Surgery) protocol. The intervention group will receive abdominal ice pack applications using ice cubes enclosed in a 30x40 cm zipped bag inside a pillowcase, positioned directly on the abdomen from the symphysis pubis to the umbilicus and spanning the distance between both anterior superior iliac spines. Based on the patient's body mass, one or two ice packs will be applied for 20 minutes every two hours during the first 24 hours postoperatively. Physiologically, ice application slows down the metabolic rate of the contact tissue, thereby reducing free radical formation, promoting local vasoconstriction to minimize inflammation and edema, and inhibiting conduction in sensory nerve fibers. The primary hypothesis of this study is that patients receiving ice pack therapy will experience lower postoperative pain scores and decreased analgesic consumption compared to those receiving standard care alone. Ultimately, this trial aims to establish high-level clinical evidence regarding the effects of abdominal ice application on postoperative pain, bowel motility, and overall patient comfort, utilizing standardized questionnaires to assess pain levels and quality of life indices

Read the detailed description

Patient Selection and HomogeneityThis study will be conducted at Muğla Sıtkı Koçman University Training and Research Hospital, Department of Obstetrics and Gynecology, Infertility and Gynecology Outpatient Clinic. A total of 122 patients aged 48-70 years scheduled for vNOTES (Vaginal Natural Orifice Transluminal Endoscopic Surgery) hysterectomy due to benign indications (such as uterine fibroids, abnormal uterine bleeding, or premalignant/malignant lesions) will be enrolled. To maintain sample homogeneity, psychological baseline levels will be evaluated using the Hospital Anxiety and Depression Scale (HADS), which features 14 items scored on a 4-point Likert scale (0-3). Only patients with a HADS anxiety subscale score of $\le$ 7 (asymptomatic/unlikely) will be included. Patients presenting with chronic pelvic pain, a history of opioid usage, endometriosis, or an anticipated requirement for extraordinary postoperative analgesia will be excluded.Preoperative Preparation and Baseline AssessmentsAll patients will receive preoperative preparation adhering to institutional Enhanced Recovery After Surgery (ERAS) protocols. Baseline routine laboratory tests, including complete blood count and biochemical profiles (hemoglobin, hematocrit, platelet count, white blood cell count, urea, creatinine, AST, ALT, CRP, sodium, potassium, and albumin), will be documented without ordering additional non-routine trials. Baseline demographic and clinical characteristics (age, body mass index, parity, history of previous operations, and surgical indications) will be recorded. No mechanical bowel preparation will be carried out preoperatively. Low-molecular-weight heparin will be administered as part of the routine thromboembolism prophylaxis.Standard Surgical Intervention and vNOTES TechniqueAll participants will undergo a standard vNOTES hysterectomy under standardized general anesthesia and endotracheal intubation. An orogastric tube will be placed for gastric decompression. A Foley catheter will be inserted preoperatively and removed at the 8th postoperative hour. Patients will be set in the dorsal lithotomy position with careful positioning to prevent hyperflexion and excessive external rotation of the hips, avoiding femoral and sciatic nerve injury.Following a standard surgical site preparation of the lower abdomen, upper thighs, and vagina, a weighted speculum will be placed into the posterior vagina to visualize the cervix, which will be held by two tenaculums (anterior and posterior). A circular incision will be performed around the cervicovaginal junction using electrocautery. The bladder will be mobilized anteriorly to enter the anterior colpotomy plane. Similarly, a posterior colpotomy will be completed by dissecting down to the insertion of the uterosacral ligaments. The anterior and posterior peritoneum will be entered and tagged with suture markers. A vNOTES advanced access platform will then be deployed vaginally, followed by carbon dioxide insufflation to create a pneumoperitoneum. Advanced bipolar electrocoagulation (LigaSure®, Covidien Company, MA, USA) will be utilized for tissue dissection and hemostasis. The vaginal cuff will be closed with a continuous polyglycolic acid (PGA) suture utilizing the Z-suture technique. Patients will be transferred to the ward after full recovery from anesthesia.Randomization and Study ArmsPatients will be sequentially enrolled and randomized in a 1:1 ratio into either the Intervention (Abdominal Ice Pack) Group or the Control (Standard Care) Group. Randomization will be executed once the patient achieves clinical stability postoperatively using Sequentially Numbered, Opaque, Sealed Envelopes (SNOSE) based on a computer-generated variable block randomization sequence.Control Group: Patients will receive standard postoperative care according to the ERAS protocol without any ice application.Intervention Group: In addition to the standard ERAS protocol, patients will receive abdominal ice therapy. Ice cubes sealed in a 30x40 cm zipped bag inside a pillowcase will be applied directly onto the lower abdomen-extending from the symphysis pubis to the umbilicus and bridging the distance between both anterior superior iliac spines. Based on the patient's body mass index, 1 or 2 ice packs will be deployed for 20 minutes every 2 hours during the first 24 hours postoperatively.Both groups will share a identical rescue analgesic protocol.Postoperative Follow-up and Outcome MeasurementsPostoperative pain levels will be dynamically tracked at the 2nd, 6th, 12th, and 24th hours, as well as at the 2nd and 6th postoperative weeks, utilizing the Visual Analog Scale (VAS) (a 100 mm line ranging from 'no pain' to 'unbearable pain'). For objective reinforcement, the Face Pain Index (0-10 score) will be recorded by blinded medical staff at the 2nd, 6th, 12th, and 24th hours. If a patient's VAS score reaches $\ge$ 4, rescue diclofenac will be given; if the VAS score is $\ge$ 6, intravenous tramadol will be administered. Every analgesic intervention, dose, and administration timestamp will be diligently logged into individual Case Report Forms (CRFs).Bowel motility will be monitored daily until hospital discharge utilizing the I-FEED scoring system, tracking oral intake, nausea, vomiting, physical examination findings, and the overall duration of symptoms. Patients and family members will be instructed to notify the research assistant immediately upon the first passage of flatus or stool. Additionally, the Quality of Recovery-15 (QoR-15) questionnaire, assessing pain, physical comfort, independence, psychological support, and emotional state across 15 questions (total score 0-150), will be completed by all patients prior to hospital discharge. All study metrics, documentation errors, or dropouts will be handled using indelible ink on printed CRFs and secured in protected archives for statistical analysis.

Being tested
Abdominal Ice Pack + ERAS
Keywords
Postoperative Pain, vNOTES Hysterectomy, Gastrointestinal Motility, Patient Comfort, Abdominal Ice Pack
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Abdominal Ice Pack + ERASProcedure or surgery

    This physical intervention involves the local application of cryotherapy onto the abdominal wall following vNOTES hysterectomy. Ice cubes are enclosed inside a 30x40 cm zipped plastic bag and placed within a textile pillowcase to provide a safe barrier. The pack is applied directly to the lower abdomen, covering the area from the symphysis pubis to the umbilicus and horizontally between both anterior superior iliac spines. Based on the patient's body mass, 1 or 2 ice packs are deployed simultaneously. This protocol is performed for exactly 20 minutes every 2 hours during the first 24 hours postoperatively. This therapy is administered strictly as an adjunct to the standard institutional Enhanced Recovery After Surgery (ERAS) protocol.

Study groups in NCT07626684
Study groupRoleWhat they receive
Abdominal Ice Pack GroupActive comparatorPatients receive abdominal ice pack therapy plus standard Enhanced Recovery After Surgery (ERAS) protocol after vNOTES hysterectomy. Ice application begins upon ward transfer after clinical stabilization. Ice cubes sealed in a 30x40 cm zipped bag inside a pillowcase are placed directly on the lower abdomen (symphysis pubis to umbilicus, between anterior superior iliac spines). One or two ice packs are applied for 20 minutes every 2 hours during the first 24 hours postoperatively. Standard ERAS care includes no bowel preparation, low-molecular-weight heparin, general anesthesia, orogastric tube, and a Foley catheter removed at the 8th postoperative hour. Postoperative pain is tracked via Visual Analog Scale (VAS) and Face Pain Index. If VAS is ≥4, rescue diclofenac is given; if ≥6, intravenous tramadol is administered."
Receives: Procedure: Abdominal Ice Pack + ERAS
Standard Control GroupNo interventionPatients receive the standard institutional Enhanced Recovery After Surgery (ERAS) protocol care alone, with absolute exclusion of any abdominal ice pack application or cryotherapy after vNOTES hysterectomy. Management adheres strictly to the standard clinical pathway without any physical interventions on the abdominal wall. ERAS care includes no preoperative mechanical bowel preparation, low-molecular-weight heparin prophylaxis, standard general anesthesia, intraoperative gastric decompression via orogastric tube, and a Foley catheter removed at the 8th postoperative hour. Pain is evaluated at the 2nd, 6th, 12th, 24th hours, and weeks 2 and 6 using the Visual Analog Scale (VAS) and Face Pain Index. Identical rescue analgesia is enforced: rescue diclofenac for VAS ≥ 4, and intravenous tramadol for VAS ≥6

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain Scores

    ostoperative pain levels will be assessed using the Visual Analog Scale (VAS), which is a 100-millimeter line ranging from 0 (no pain) to 100 (unbearable pain). Higher scores indicate more severe pain

    Measured: Postoperative 2nd, 6th, 12th, and 24th hours, and postoperative 2nd and 6th weeks.

Secondary outcomes (4)
  1. Total Rescue Analgesic Consumption

    Total doses of rescue diclofenac or tramadol administered will be documented in milligrams.

    Measured: During the first 24 hours postoperatively

  2. Postoperative Quality of Life

    Measured using the 15-item Quality of Recovery questionnaire (total score ranges from 0-150 )

    Measured: Postoperative Day 1

  3. Postoperative Gastrointestinal Function

    Monitored using the standardized I-FEED scoring system to evaluate bowel motility

    Measured: Through hospital discharge, up to 3 days

  4. Postoperative Surgical Satisfaction Scores

    Assessed via SSQ-8 (8 Likert items, scores 8 to 40; higher scores indicate better satisfaction)

    Measured: Postoperative Day 2 Through hospital discharge, an average of 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion15 Feb 2027 (estimated)
  4. Study completion15 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Arm 1: Experimental Arm Title: Abdominal Ice Pack Group Arm Description: Patients in this group will receive standard postoperative care according to the ERAS protocol, with the addition of abdominal ice pack application. Arm 2: Active Comparator Arm Title: Control Group Arm Description: Patients in this group will receive standard postoperative care according to the ERAS protocol alone, without any ice application.
Masking
None (open label)
Enrolment
122 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07626684
Sponsor's protocol ID
M09
Status last verified
May 2026
First submitted
22 May 2026
Last updated
4 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data that underlie the results reported in this article will be made available upon reasonable request

Questions about this trial

What is this clinical trial studying?

A study testing Abdominal Ice Pack + ERAS in people with Hysterectomy, Benign Uterine Diseases and Hysterectomy, Vaginal, run by Erzincan Military Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 4 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain Scores (time frame: Postoperative 2nd, 6th, 12th, and 24th hours, and postoperative 2nd and 6th weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in